Form 4: Crexendo Director Kevin Jackson Granted 10,000 Stock Options

Crexendo, Inc. Director Kevin Jackson was granted 10,000 stock options with an exercise price of $6.47, vesting monthly over three years.

Summary

• Kevin Arnold Jackson, a Director of Crexendo, Inc. (CXDO), was granted 10,000 stock options.
• The options have an exercise price of $6.47 per share.
• These options will vest in 36 equal monthly installments, commencing on April 4, 2026.
• The expiration date for these stock options is March 4, 2036.
• Following this transaction, Mr. Jackson beneficially owns 10,000 derivative securities.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents routine director compensation that aligns interests without indicating any immediate operational or financial changes.

Positives

• The grant of stock options aligns the director's interests with long-term shareholder value creation.
• A 10-year expiration date provides ample time for potential value realization.

Future Outlook

The stock options will vest over 36 equal monthly installments starting April 4, 2026, indicating a long-term incentive structure for the director.

Industry Context

StockSavvy.ai notes that granting stock options to directors is a common practice in the technology and telecommunications industry, aiming to incentivize long-term performance and align leadership interests with shareholder returns. This type of compensation is standard for companies like Crexendo, which operates in the cloud communications and services sector.

Comparison to Industry Standards

• StockSavvy.ai observes that a 10-year option term is typical for executive and director compensation plans across various industries, including tech and telecom.
• The vesting schedule of 36 equal monthly installments is a common approach to ensure continued service and performance alignment, comparable to practices at companies such as RingCentral (RNG) or 8x8 (EGHT) for their non-employee directors.
• The exercise price being at or above the market price on the grant date (implied by the lack of a discount) is standard for incentive stock options.

Related Party Transactions

• The grant of stock options to a director is a related party transaction, but it is a standard form of compensation disclosed as required.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with long-term shareholder value. Potential dilution from option exercise is a long-term consideration.
• Employees: No direct impact on employees is mentioned.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is mentioned.

Next Steps

• The stock options will begin vesting on April 4, 2026, over a 36-month period.
• The director may choose to exercise vested options at any point before the March 4, 2036 expiration date.

Key Dates

Recommendation

This Form 4 filing reports a routine compensation event for a director and does not contain information that would fundamentally alter the investment thesis for Crexendo, Inc. It is a standard disclosure of an insider transaction, not indicative of significant operational changes or financial performance shifts. Therefore, a "hold" recommendation is appropriate as it provides no new material information to change an existing position.

Keywords

Crexendo, CXDO, Stock Options, Insider Trading, Form 4, Director Compensation, Equity Grant, Kevin Jackson